Table 4

Prevalence of MES (with relative risk) and indicators of cardiovascular risk (split according to gender)
Male n = 62, (%) Female n = 77, (%) Total n, (%) χ2, P-value*
Metabolic Syndrome present 19 (31) 30 (39) 49 (35) NS
Relative Risk of Metabolic Syndrome (95% CI, P value)** 1.737 (1.18-2.54, p < 0.01) 2.230 (1.67-2.97, p < 0.01) 2.008 (1.59-2.53, p < 0.01)
BMI overweight- Hong Kong criterion (≥23) 48 (77) 63 (82) 111 (80) NS
BMI overweight- International criterion (≥25) 34 (55) 45 (58) 79 (57) NS
Waist Circumference (males ≥90 cm, females ≥ 80 cm) 20 (32) 47 (61) 67 (48) χ2 = 11.40, p < 0.01
Hypertension – Blood pressure ≥ 140/90 12 (19) 21 (27) 33 (24) NS
Hypercholesterolemia – Total Cholesterol ≥6.2 mmol/L 15 (24) 16 (21) 31 (22) NS
Raised LDL cholesterol – LDL ≥ 4.1 mmol/L 11 (18) 12 (16) 23 (16) NS
Reduced HDL cholesterol – HDL <1.00 mmol/L (males), <1.30 mmol/L (females) 13 (21) 19 (25) 32 (23) NS
Raised fasting plasma glucose - ≥ 7.00 mmol/L 8 (13) 9 (12) 17 (12) NS
Raised triglycerides - ≥2.2 mmol/L 17 (27) 17 (22) 34 (25) NS

*P for significant differences in cardiovascular risk according to gender, tested by χ2 test.

NS = not statistically significant.

** Data reported by Ko and Tang [6] for the prevalence of MES in the general Hong Kong population was used to calculate the relative risk in this sample.

Bressington et al.

Bressington et al. BMC Psychiatry 2013 13:87   doi:10.1186/1471-244X-13-87

Open Data